LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 17.28 | 27.76 | 640 | 838 | 0.7631 | 0.8930 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 17.28 | 27.76 | 178 | 838 | 0.2122 | 0.4592 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 17.28 | 27.76 | 894 | 838 | 1.0659 | 1.0261 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 18.98 | 27.76 | 1 | 941 | 0.0011 | -0.4799 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 18.98 | 27.76 | 615 | 941 | 0.6535 | 0.8394 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 18.98 | 27.76 | 94 | 941 | 0.0999 | 0.2712 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 18.98 | 27.76 | 871 | 941 | 0.9255 | 0.9698 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 20.68 | 27.76 | 1 | 1119 | 0.0009 | -0.4638 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 20.68 | 27.76 | 625 | 1119 | 0.5585 | 0.7931 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 20.68 | 27.76 | 124 | 1119 | 0.1108 | 0.3240 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 20.68 | 27.76 | 873 | 1119 | 0.7802 | 0.9090 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 22.39 | 27.76 | 1 | 1305 | 0.0008 | -0.4502 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 22.39 | 27.76 | 601 | 1305 | 0.4603 | 0.7393 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 22.39 | 27.76 | 68 | 1305 | 0.0521 | 0.1750 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 22.39 | 27.76 | 845 | 1305 | 0.6472 | 0.8493 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 24.09 | 27.76 | 1 | 1461 | 0.0007 | -0.4408 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 24.09 | 27.76 | 548 | 1461 | 0.3749 | 0.6847 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 24.09 | 27.76 | 32 | 1461 | 0.0219 | 0.0252 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 24.09 | 27.76 | 817 | 1461 | 0.5590 | 0.8066 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 25.79 | 27.76 | 2 | 1605 | 0.0012 | -0.3620 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 25.79 | 27.76 | 527 | 1605 | 0.3283 | 0.6535 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 25.79 | 27.76 | 22 | 1605 | 0.0137 | -0.0389 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 25.79 | 27.76 | 792 | 1605 | 0.4934 | 0.7726 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 27.49 | 27.76 | 2 | 1723 | 0.0012 | -0.3570 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 27.49 | 27.76 | 524 | 1723 | 0.3041 | 0.6377 | MN20160318_Q01 | D13 |